医療用医薬品専業の中堅。自社開発品多い。先駆的がん免疫阻害剤「オプジーボ」が成長牽引
開示年月日 | 決算期 | 種別 | 連個 | 実予 | 売上収益 | 営業利益 | 税前利益 | 当期利益 | 配当 | 1Q | 2Q | 3Q |
---|---|---|---|---|---|---|---|---|---|---|---|---|
2006/05/15 | 2006/03 | 年度 | 連 | 実 | 148,671 | 56,936 | 59,245 | 36,146 | 80 | 0 | 0 | 0 |
2006/05/15 | 2006/09 | 中間 | 連 | 予 | 70,600 | 28,800 | 17,800 | 0 | 0 | 40 | 0 | |
2006/11/09 | 2006/09 | 中間 | 連 | 実 | 69,462 | 27,084 | 29,097 | 18,231 | 0 | 0 | 40 | 0 |
2006/05/15 | 2007/03 | 年度 | 連 | 予 | 144,200 | 56,300 | 35,100 | 80 | 0 | 40 | 0 | |
2007/05/14 | 2007/03 | 年度 | 連 | 実 | 141,711 | 52,841 | 56,587 | 35,271 | 100 | 0 | 40 | 0 |
2007/05/14 | 2007/09 | 中間 | 連 | 予 | 72,500 | 28,100 | 29,500 | 18,300 | 0 | 0 | 90 | 0 |
2007/11/08 | 2007/09 | 中間 | 連 | 実 | 71,329 | 26,469 | 27,953 | 17,175 | 0 | 0 | 90 | 0 |
2007/05/14 | 2008/03 | 年度 | 連 | 予 | 147,300 | 55,800 | 58,100 | 35,300 | 180 | 0 | 90 | 0 |
2008/05/14 | 2008/03 | 年度 | 連 | 実 | 145,897 | 52,286 | 55,103 | 35,046 | 202 | 0 | 90 | 0 |
2008/08/05 | 2008/06 | 1Q | 連 | 実 | 35,659 | 12,439 | 13,713 | 8,721 | 0 | 0 | 0 | 0 |
2008/05/14 | 2008/09 | 2Q | 連 | 予 | 69,300 | 23,100 | 24,800 | 16,400 | 0 | 0 | 90 | 0 |
2008/08/05 | 2008/09 | 2Q | 連 | 予 | 65,800 | 19,500 | 21,200 | 14,200 | 0 | 0 | 90 | 0 |
2008/11/06 | 2008/09 | 2Q | 連 | 実 | 65,993 | 20,711 | 22,478 | 13,883 | 0 | 0 | 90 | 0 |
2009/02/05 | 2008/12 | 3Q | 連 | 実 | 104,254 | 35,150 | 37,938 | 20,853 | 0 | 0 | 90 | 0 |
2008/05/14 | 2009/03 | 年度 | 連 | 予 | 143,000 | 46,100 | 49,100 | 32,100 | 180 | 0 | 90 | 0 |
2008/08/05 | 2009/03 | 年度 | 連 | 予 | 134,400 | 39,600 | 42,600 | 28,400 | 180 | 0 | 90 | 0 |
2008/11/06 | 2009/03 | 年度 | 連 | 予 | 134,400 | 39,600 | 42,600 | 27,200 | 180 | 0 | 90 | 0 |
2009/02/05 | 2009/03 | 年度 | 連 | 予 | 134,400 | 39,600 | 42,600 | 24,500 | 180 | 0 | 90 | 0 |
2009/05/13 | 2009/03 | 年度 | 連 | 実 | 136,556 | 43,471 | 46,752 | 23,766 | 180 | 0 | 90 | 0 |
2009/08/04 | 2009/06 | 1Q | 連 | 実 | 36,448 | 15,826 | 16,999 | 11,174 | 0 | 0 | 0 | 0 |
2009/05/13 | 2009/09 | 2Q | 連 | 予 | 66,500 | 18,200 | 19,400 | 12,100 | 0 | 0 | 90 | 0 |
2009/08/04 | 2009/09 | 2Q | 連 | 予 | 66,500 | 20,500 | 21,700 | 13,500 | 0 | 0 | 90 | 0 |
2009/11/15 | 2009/09 | 2Q | 連 | 実 | 67,184 | 22,382 | 24,107 | 15,914 | 0 | 0 | 90 | 0 |
2010/02/04 | 2009/12 | 3Q | 連 | 実 | 106,325 | 34,541 | 37,185 | 24,592 | 0 | 0 | 90 | 0 |
2009/05/13 | 2010/03 | 年度 | 連 | 予 | 137,900 | 40,500 | 42,900 | 27,000 | 180 | 0 | 90 | 0 |
2009/11/15 | 2010/03 | 年度 | 連 | 予 | 137,900 | 40,500 | 42,900 | 28,300 | 180 | 0 | 90 | 0 |
2010/02/04 | 2010/03 | 年度 | 連 | 予 | 139,300 | 40,700 | 43,500 | 28,700 | 180 | 0 | 90 | 0 |
2010/05/13 | 2010/03 | 年度 | 連 | 実 | 135,986 | 39,840 | 42,711 | 27,878 | 180 | 0 | 90 | 0 |
2010/08/06 | 2010/06 | 1Q | 連 | 実 | 33,830 | 11,739 | 12,869 | 8,322 | 0 | 0 | 0 | 0 |
2010/05/13 | 2010/09 | 2Q | 連 | 予 | 62,000 | 16,900 | 18,200 | 11,800 | 0 | 0 | 90 | 0 |
2010/09/08 | 2010/09 | 2Q | 連 | 予 | 62,000 | 11,300 | 12,600 | 8,000 | 0 | 0 | 90 | 0 |
2010/11/04 | 2010/09 | 2Q | 連 | 実 | 63,778 | 13,098 | 14,769 | 9,325 | 0 | 0 | 90 | 0 |
2011/02/02 | 2010/12 | 3Q | 連 | 実 | 101,609 | 27,280 | 29,920 | 19,007 | 0 | 0 | 90 | 0 |
2010/05/13 | 2011/03 | 年度 | 連 | 予 | 129,000 | 32,000 | 34,000 | 22,100 | 180 | 0 | 90 | 0 |
2010/09/08 | 2011/03 | 年度 | 連 | 予 | 129,000 | 26,700 | 28,700 | 18,500 | 180 | 0 | 90 | 0 |
2011/02/02 | 2011/03 | 年度 | 連 | 予 | 131,000 | 29,900 | 31,900 | 20,500 | 180 | 0 | 90 | 0 |
2011/05/11 | 2011/03 | 年度 | 連 | 実 | 135,255 | 35,200 | 37,541 | 24,222 | 180 | 0 | 90 | 0 |
2011/08/02 | 2011/06 | 1Q | 連 | 実 | 36,328 | 12,182 | 13,371 | 8,345 | 0 | 0 | 0 | 0 |
2011/05/11 | 2011/09 | 2Q | 連 | 予 | 67,200 | 15,800 | 17,100 | 11,100 | 0 | 0 | 90 | 0 |
2011/10/20 | 2011/09 | 2Q | 連 | 予 | 70,000 | 17,600 | 19,000 | 8,300 | 0 | 0 | 90 | 0 |
2011/11/02 | 2011/09 | 2Q | 連 | 実 | 70,170 | 17,678 | 19,191 | 8,382 | 0 | 0 | 90 | 0 |
2012/02/02 | 2011/12 | 3Q | 連 | 実 | 112,785 | 33,418 | 35,888 | 17,674 | 0 | 0 | 90 | 0 |
2011/05/11 | 2012/03 | 年度 | 連 | 予 | 140,000 | 35,700 | 37,800 | 24,500 | 180 | 0 | 90 | 0 |
2011/11/02 | 2012/03 | 年度 | 連 | 予 | 145,400 | 36,200 | 38,400 | 21,000 | 180 | 0 | 90 | 0 |
2012/02/02 | 2012/03 | 年度 | 連 | 予 | 145,400 | 36,200 | 38,400 | 18,800 | 180 | 0 | 90 | 0 |
2012/04/23 | 2012/03 | 年度 | 連 | 予 | 145,400 | 37,600 | 40,000 | 23,800 | 180 | 0 | 90 | 0 |
2012/05/09 | 2012/03 | 年度 | 連 | 実 | 145,778 | 37,904 | 40,454 | 24,360 | 180 | 0 | 90 | 0 |
2012/08/02 | 2012/06 | 1Q | 連 | 実 | 37,652 | 12,079 | 13,156 | 8,421 | 0 | 0 | 0 | 0 |
2012/05/09 | 2012/09 | 2Q | 連 | 予 | 70,200 | 14,900 | 16,100 | 10,800 | 0 | 0 | 90 | 0 |
2012/11/05 | 2012/09 | 2Q | 連 | 実 | 71,111 | 17,506 | 18,952 | 11,072 | 0 | 0 | 90 | 0 |
2013/02/04 | 2012/12 | 3Q | 連 | 実 | 112,369 | 28,872 | 31,303 | 20,941 | 0 | 0 | 90 | 0 |
2012/05/09 | 2013/03 | 年度 | 連 | 予 | 146,200 | 32,700 | 34,100 | 23,000 | 180 | 0 | 90 | 0 |
2013/05/13 | 2013/03 | 年度 | 連 | 実 | 145,393 | 31,921 | 33,953 | 24,120 | 180 | 0 | 90 | 0 |
2014/05/13 | 2013/03 | 年度 | IFRS | 遡 | 142,806 | 29,935 | 33,001 | 22,919 | 180 | 0 | 90 | 0 |
2013/08/02 | 2013/06 | 1Q | 連 | 実 | 37,909 | 8,122 | 9,354 | 6,471 | 0 | 0 | 0 | 0 |
2014/08/04 | 2013/06 | 1Q | IFRS | 遡 | 37,299 | 10,120 | 11,476 | 7,991 | 0 | 0 | 0 | 0 |
2013/05/13 | 2013/09 | 2Q | 連 | 予 | 72,600 | 11,700 | 12,900 | 9,000 | 0 | 0 | 90 | 0 |
2013/11/05 | 2013/09 | 2Q | 連 | 実 | 71,702 | 13,156 | 14,598 | 10,157 | 0 | 0 | 90 | 0 |
2014/11/05 | 2013/09 | 2Q | IFRS | 遡 | 70,740 | 15,041 | 16,649 | 11,530 | 0 | 0 | 90 | 0 |
2014/02/04 | 2013/12 | 3Q | 連 | 実 | 112,922 | 23,303 | 26,093 | 18,395 | 0 | 0 | 90 | 0 |
2015/02/03 | 2013/12 | 3Q | IFRS | 遡 | 111,424 | 25,590 | 28,715 | 19,883 | 0 | 0 | 90 | 0 |
2013/05/13 | 2014/03 | 年度 | 連 | 予 | 148,300 | 27,900 | 29,000 | 20,400 | 180 | 0 | 90 | 0 |
2014/05/13 | 2014/03 | 年度 | IFRS | 実 | 143,247 | 26,423 | 29,458 | 20,350 | 180 | 0 | 90 | 0 |
2015/05/12 | 2014/03 | 年度 | IFRS | 遡 | 143,247 | 26,429 | 29,464 | 20,344 | 180 | 0 | 90 | 0 |
2014/08/04 | 2014/06 | 1Q | IFRS | 実 | 31,808 | 2,777 | 3,958 | 2,908 | 0 | 0 | 0 | 0 |
2014/05/13 | 2014/09 | 2Q | IFRS | 予 | 68,100 | 10,300 | 11,750 | 8,600 | 0 | 0 | 90 | 0 |
2014/10/08 | 2014/09 | 2Q | IFRS | 予 | 62,300 | 3,200 | 4,800 | 3,400 | 0 | 0 | 90 | 0 |
2014/11/05 | 2014/09 | 2Q | IFRS | 実 | 62,381 | 3,026 | 4,697 | 3,281 | 0 | 0 | 90 | 0 |
2015/02/03 | 2014/12 | 3Q | IFRS | 実 | 107,267 | 16,474 | 19,799 | 15,708 | 0 | 0 | 90 | 0 |
2014/05/13 | 2015/03 | 年度 | IFRS | 予 | 139,000 | 19,200 | 21,800 | 16,000 | 180 | 0 | 90 | 0 |
2014/11/05 | 2015/03 | 年度 | IFRS | 予 | 129,400 | 13,100 | 15,700 | 10,900 | 180 | 0 | 90 | 0 |
2015/02/03 | 2015/03 | 年度 | IFRS | 予 | 137,100 | 15,100 | 17,700 | 12,000 | 180 | 0 | 90 | 0 |
2015/05/12 | 2015/03 | 年度 | IFRS | 実 | 135,775 | 14,794 | 18,305 | 12,976 | 180 | 0 | 90 | 0 |
2015/08/04 | 2015/06 | 1Q | IFRS | 実 | 35,696 | 11,674 | 13,208 | 9,453 | 0 | 0 | 0 | 0 |
2015/05/12 | 2015/09 | 2Q | IFRS | 予 | 64,100 | 7,500 | 8,800 | 6,300 | 0 | 0 | 90 | 0 |
2015/10/26 | 2015/09 | 2Q | IFRS | 予 | 70,300 | 14,500 | 16,000 | 11,900 | 0 | 0 | 90 | 0 |
2015/11/04 | 2015/09 | 2Q | IFRS | 実 | 70,303 | 14,404 | 15,904 | 11,873 | 0 | 0 | 90 | 0 |
2016/02/02 | 2015/12 | 3Q | IFRS | 実 | 112,419 | 22,324 | 25,112 | 19,181 | 0 | 0 | 90 | 0 |
2015/05/12 | 2016/03 | 年度 | IFRS | 予 | 135,100 | 14,000 | 16,500 | 11,600 | 180 | 0 | 90 | 0 |
2015/11/04 | 2016/03 | 年度 | IFRS | 予 | 144,500 | 15,200 | 17,800 | 13,100 | 180 | 0 | 90 | 0 |
2016/02/02 | 2016/03 | 年度 | IFRS | 予 | 156,000 | 24,000 | 26,500 | 18,600 | 180 | 0 | 90 | 0 |
2016/05/06 | 2016/03 | 年度 | IFRS | 予 | 160,000 | 30,000 | 33,000 | 25,000 | 180 | 0 | 90 | 0 |
2016/05/11 | 2016/03 | 年度 | IFRS | 実 | 160,284 | 30,507 | 33,272 | 24,979 | 180 | 0 | 90 | 0 |
2016/08/02 | 2016/06 | 1Q | IFRS | 実 | 58,757 | 17,244 | 18,245 | 13,680 | 0 | 0 | 0 | 0 |
2016/05/11 | 2016/09 | 2Q | IFRS | 予 | 116,500 | 27,500 | 29,000 | 21,500 | 0 | 0 | 20 | 0 |
2016/11/07 | 2016/09 | 2Q | IFRS | 実 | 117,728 | 30,135 | 31,127 | 23,119 | 0 | 0 | 20 | 0 |
2017/02/02 | 2016/12 | 3Q | IFRS | 実 | 188,845 | 53,303 | 56,193 | 42,472 | 0 | 0 | 20 | 0 |
2016/05/11 | 2017/03 | 年度 | IFRS | 予 | 259,000 | 72,500 | 75,000 | 55,800 | 40 | 0 | 20 | 0 |
2016/05/11 | 2017/03 | 年度 | IFRS | 予 | 240,000 | 54,000 | 56,000 | 41,800 | 40 | 0 | 20 | 0 |
2017/02/02 | 2017/03 | 年度 | IFRS | 予 | 240,000 | 68,500 | 70,500 | 52,300 | 40 | 0 | 20 | 0 |
2017/05/11 | 2017/03 | 年度 | IFRS | 実 | 244,797 | 72,284 | 74,540 | 55,793 | 40 | 0 | 20 | 0 |
2017/08/02 | 2017/06 | 1Q | IFRS | 実 | 60,913 | 14,275 | 15,796 | 11,774 | 0 | 0 | 0 | 0 |
2017/05/11 | 2017/09 | 2Q | IFRS | 予 | 112,500 | 13,200 | 14,500 | 10,700 | 0 | 0 | 25 | 0 |
2017/10/26 | 2018/03 | 2Q | IFRS | 予 | 121,000 | 26,700 | 28,300 | 21,200 | 0 | 0 | 25 | 0 |
2017/11/06 | 2017/09 | 2Q | IFRS | 実 | 121,446 | 26,789 | 28,393 | 21,210 | 0 | 0 | 25 | 0 |
2018/02/02 | 2017/12 | 3Q | IFRS | 実 | 200,570 | 52,191 | 55,333 | 41,439 | 0 | 0 | 25 | 0 |
2017/05/11 | 2018/03 | 年度 | IFRS | 予 | 236,000 | 36,500 | 39,000 | 29,000 | 45 | 0 | 25 | 0 |
2017/11/06 | 2018/03 | 年度 | IFRS | 予 | 254,000 | 50,000 | 53,000 | 39,500 | 45 | 0 | 25 | 0 |
2018/02/02 | 2018/03 | 年度 | IFRS | 予 | 260,000 | 54,500 | 57,500 | 43,000 | 45 | 0 | 25 | 0 |
2018/05/10 | 2018/03 | 年度 | IFRS | 実 | 261,836 | 60,684 | 63,922 | 50,284 | 45 | 0 | 25 | 0 |
2018/08/01 | 2018/06 | 1Q | IFRS | 実 | 71,242 | 17,980 | 19,428 | 15,236 | 0 | 0 | 0 | 0 |
2018/05/10 | 2018/09 | 2Q | IFRS | 予 | 134,500 | 28,500 | 30,000 | 23,000 | 0 | 0 | 22.5 | 0 |
2018/11/01 | 2018/09 | 2Q | IFRS | 実 | 144,395 | 35,151 | 36,917 | 28,845 | 0 | 0 | 22.5 | 0 |
2019/02/01 | 2018/12 | 3Q | IFRS | 実 | 223,197 | 52,146 | 55,234 | 43,133 | 0 | 0 | 22.5 | 0 |
2018/05/10 | 2019/03 | 年度 | IFRS | 予 | 277,000 | 61,500 | 65,000 | 50,500 | 45 | 0 | 22.5 | 0 |
2018/11/01 | 2019/03 | 年度 | IFRS | 予 | 280,000 | 63,500 | 67,000 | 52,000 | 45 | 0 | 22.5 | 0 |
2019/05/09 | 2019/03 | 年度 | IFRS | 実 | 288,634 | 62,010 | 65,141 | 51,539 | 45 | 0 | 22.5 | 0 |
2019/08/01 | 2019/06 | 1Q | IFRS | 実 | 73,982 | 19,980 | 21,196 | 16,330 | 0 | 0 | 0 | 0 |
2019/05/09 | 2019/09 | 2Q | IFRS | 予 | 非開示 | 0 | 0 | 22.5 | 0 | |||
2019/10/31 | 2019/09 | 2Q | IFRS | 実 | 149,008 | 41,878 | 43,042 | 32,816 | 0 | 0 | 22.5 | 0 |
2020/01/31 | 2019/12 | 3Q | IFRS | 実 | 225,299 | 66,045 | 68,687 | 51,827 | 0 | 0 | 22.5 | 0 |
2019/05/09 | 2020/03 | 年度 | IFRS | 予 | 290,000 | 67,000 | 70,000 | 53,000 | 45 | 0 | 22.5 | 0 |
2020/01/31 | 2020/03 | 年度 | IFRS | 予 | 290,000 | 71,000 | 73,000 | 55,000 | 45 | 0 | 22.5 | 0 |
2020/05/12 | 2020/03 | 年度 | IFRS | 実 | 292,420 | 77,491 | 79,696 | 59,704 | 45 | 0 | 22.5 | 0 |
2020/07/31 | 2020/06 | 1Q | IFRS | 実 | 74,913 | 27,043 | 28,307 | 21,496 | 0 | 0 | 0 | 0 |
2020/05/12 | 2020/09 | 2Q | IFRS | 予 | 非開示 | 0 | 0 | 22.5 | 0 | |||
2020/10/29 | 2020/09 | 2Q | IFRS | 実 | 150,474 | 52,401 | 53,674 | 39,849 | 0 | 0 | 22.5 | 0 |
2021/02/01 | 2020/12 | 3Q | IFRS | 実 | 234,933 | 82,189 | 84,658 | 66,487 | 0 | 0 | 22.5 | 0 |
2020/05/12 | 2021/03 | 年度 | IFRS | 予 | 303,000 | 80,000 | 82,000 | 61,000 | 45 | 0 | 22.5 | 0 |
2020/10/29 | 2021/03 | 年度 | IFRS | 予 | 305,000 | 87,000 | 88,500 | 65,000 | 45 | 0 | 22.5 | 0 |
2021/02/01 | 2021/03 | 年度 | IFRS | 予 | 309,000 | 94,000 | 95,500 | 74,000 | 45 | 0 | 22.5 | 0 |
2021/04/28 | 2021/03 | 年度 | IFRS | 予 | 309,000 | 94,000 | 95,500 | 74,000 | 50 | 0 | 22.5 | 0 |
2021/05/11 | 2021/03 | 年度 | IFRS | 実 | 309,284 | 98,330 | 100,890 | 75,425 | 50 | 0 | 22.5 | 0 |
2021/05/11 | 2021/09 | 2Q | IFRS | 予 | 非開示 | 0 | 0 | 28 | 0 | |||
2021/05/11 | 2022/03 | 年度 | IFRS | 予 | 350,000 | 105,000 | 107,000 | 83,000 | 56 | 0 | 28 | 0 |
2021/05/13 | 2021/03 | 年度 | IFRS | 予 | 345,000 | 103,000 | 105,000 | 81,500 | 56 | 0 | 28 | 0 |
2016/4に株式分割(1→5)
小野薬